NCT00777361View on ClinicalTrials.gov

Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers

PHASE1TerminatedINTERVENTIONAL

Enrollment

9

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Alzheimer's Disease

Interventions

DRUG

AZD3480

Iv single dose, 4-hour infusion of 25 mg

DRUG

AZD3480

Oral solution single dose of 50 mg

Trial Locations (1)

Unknown

Research site, Macclesfield

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY

NCT00777361 - Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers | Biotech Hunter | Biotech Hunter